Biofrontera Inc. has received patent approval for an updated formulation of Ameluz®, extending patent protection until December 2043. This formulation, which has been in use since FDA approval in 2024 ...
Jessica Soohoo, a 20-year-old student in New Jersey, was supposed to start her sixth and final month of isotretinoin acne treatment in December. Isotretinoin is the generic name for Absorica, Claravis ...
SAN DIEGO, CA / ACCESSWIRE / November 16, 2023 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback